Epidemiologic data on the incidence of different types of pyelonephritis are limited. It is known that the incidence of acute pyelonephritis is highest in otherwise healthy women between 15 and 29 years of age, followed by infants and older persons.
DiastatÂ® comes in easy-to-use, prepackaged, pre -measured doses. It requires no refrigeration or special handling and has a 4-year shelf life. DiastatÂ® comes in 10 mg or 20 mg syringes for use in adults with a range of dosing from 5 mg to 20 mg. The pharmacist will dial in the correct dose on the pre-filled syringe and lock it into place. A green âREADYâ band should be visible when the unit is locked. Side effects There may be side effects to the use of DiastatÂ® which include:
Treatment should be initiated with a dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Dosage should be increased by 1000 mg/day every 2 weeks to the recommended daily dose of 3000 mg. The effectiveness of doses lower than 3000 mg/day has not been adequately studied.EPPRA is given orally with or without food. The KEPPRA dosing regimen depends on the indication, age group, dosage form (tablets or oral solution), and renal function. Prescribe the oral solution for pediatric patients with body weight â¤ 20 kg.